Patents by Inventor Denis Martin

Denis Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20100119507
    Abstract: The present invention relates to antigens, more particularly antigenS of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: September 28, 2009
    Publication date: May 13, 2010
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • NOVEL STREPTOCOCCUS ANTIGENS
    Publication number: 20100093035
    Abstract: Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: December 9, 2009
    Publication date: April 15, 2010
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Josee Hamel, Bernard R. Brodeur, Isabelle Pineau, Denis Martin, Clement Rioux, Nathalie Charland
  • Fusion Protein
    Publication number: 20100029912
    Abstract: Fusion proteins comprising an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1, which may further comprise carriers, fusion partners, or the like, are provided. Methods for preparing, formulating, and using such fusion proteins are also provided. Such proteins are useful a vaccine components for inducing an immune response against a range of cancer-antigen-bearing cells.
    Type: Application
    Filed: July 15, 2009
    Publication date: February 4, 2010
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Normand Blais, Martine Boyer, Vincent Brichard, Jamila Louahed, Denis Martin, Remi Palmantier, Clement Rioux
  • antigens
    Patent number: 7635482
    Abstract: Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: December 22, 2009
    Assignee: ID Biomedical Corporation
    Inventors: Josee Hamel, Bernard R. Brodeur, Isabelle Pineau, Denis Martin, Clement Rioux, Nathalie Charland
  • METHOD AND APPARATUS FOR MATCHING TRANSLUCENT COATINGS OF ABSORBENT SUBSTRATES
    Publication number: 20090248338
    Abstract: In one embodiment, the present invention is a method and apparatus for matching translucent coatings of absorbent substrates. In one embodiment, a method for matching a color of a sample includes generating a plurality of recipes, each of the recipes representing a mixture of one colorant and a clear vehicle and defining a concentration of the one colorant and a concentration of the clear vehicle, applying each of the recipes to one or more absorbent substrates, determining an absorption value and a scattering value for each of the recipes as applied to the absorbent substrates, storing the recipes in a database, where each of the recipes is stored with an associated absorption value and an associated scattering value, selecting a first recipe from among the recipes stored in the database, and evaluating a quality of the first recipe as a match to the color of the sample.
    Type: Application
    Filed: March 27, 2009
    Publication date: October 1, 2009
    Inventor: DENIS MARTIN
  • antigens and corresponding DNA fragments
    Patent number: 7595057
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: September 29, 2009
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • STREPTOCOCCUS PYOGENES POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20090186820
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Application
    Filed: January 12, 2009
    Publication date: July 23, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • Magnetometric Device for Evaluating a Physical Parameter, and Use
    Publication number: 20090165573
    Abstract: A magnetometric device for evaluating a physical parameter (D, K), comprising a circuit (1) which is sensitive to a magnetic field, a measurement circuit (2) and a magnetic field generator (3), the sensitive circuit (1) being subjected to a magnetic field which varies with the physical parameter to be measured and having an electrical characteristic which is evaluated by the measurement circuit and which varies as a function of the magnetic field. The field generator (3) is designed to reverse the polarity of the applied magnetic field, the evaluation of the physical parameter thus being able to be corrected of the parasitic influence of the terrestrial magnetic field.
    Type: Application
    Filed: December 22, 2008
    Publication date: July 2, 2009
    Applicant: Michelin Recherche et Technique S.A.
    Inventors: Thomas Ledoux, Nathalie Levain, Denis Martin
  • MORAXELLA (BRANHAMELLA) CATARRHALIS ANTIGENS
    Publication number: 20090074807
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamella) catarrhalis which may be useful for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: July 15, 2008
    Publication date: March 19, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • GROUP B STREPTOCOCCUS ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20090042794
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: June 9, 2008
    Publication date: February 12, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Martine Boyer
  • polypeptides and corresponding DNA fragments
    Patent number: 7482012
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: January 27, 2009
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • Polypeptides of
    Patent number: 7459165
    Abstract: The present invention relates to polypeptides of Pseudomonas aeruginosa which may be used to prevent, diagnose and/or treat Pseudomonas aeruginosa infection.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: December 2, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Nathalie Charland, Josee Hamel, Bernard Brodeur, Denis Martin, Isabelle Charlebois, Diane Bussiere
  • BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS
    Publication number: 20080227706
    Abstract: Group B Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Application
    Filed: January 22, 2008
    Publication date: September 18, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee Hamel, Bernard R. Brodeur
  • Polypeptides of ()
    Patent number: 7410648
    Abstract: The present invention relates to polypeptides, more particularly polypeptides of Moraxella (Branhamella) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (Branhamella) catarrhalis infection.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • () antigens
    Patent number: 7410645
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) catarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: August 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • VACCINE
    Publication number: 20080187535
    Abstract: The present invention relates to fusion proteins comprising an antigen derived from the so-called tumour rejection antigen PRAME (also known as DAGE) linked to an immunological fusion partner which provides T helper epitopes, such as, for example protein D from Haemophilus influenzae B, fusion partner proteins comprising fragments of protein D, methods for preparing the same and for formulating vaccines and use of the same for treating a range of cancers.
    Type: Application
    Filed: January 11, 2008
    Publication date: August 7, 2008
    Inventors: Normand Blais, Denis Martin, Remi M. Palmantier
  • Fuel System
    Publication number: 20080169143
    Abstract: A system comprises a pressure raising valve having a valve member movable within a bore between a closed position and an open position in which fuel supplied to the pressure raising valve from a metering valve, in use, is delivered to an engine manifold, the valve member being urged towards its closed position by the fuel pressure within a control chamber, the pressure raising valve including a low pressure port which communicates with the control chamber when the valve member is in its closed position, the valve member closing the low pressure port upon movement thereof away from its closed position beyond a predetermined distance.
    Type: Application
    Filed: December 27, 2007
    Publication date: July 17, 2008
    Applicant: Goodrich Control Systems Limited
    Inventor: Denis Martin O'Shea
  • Group B antigens and corresponding DNA fragments
    Patent number: 7393536
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: July 1, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
  • PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
    Publication number: 20080124337
    Abstract: The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoeae strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 29, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
    Publication number: 20080124353
    Abstract: The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoeae strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 29, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux